Oncology
Advancing the case for cell and gene therapies
After the Advanced Therapies Congress, Europe, pharmaphorum spoke with Resolution Therapeutics' Lara Campana and Vianautis' Dr Sam Barker.
News
Jeito closes 'record' $1.2bn Europe-focused biopharma fund
Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.
Oncology
Radiopharmaceutical development is accelerating. Preclinical...
Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development.
News
Gilead strikes again, penning $5bn deal to buy Tubulis
Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
News
AZ claims another win for Imfinzi in frontline liver cancer
AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
